Oakland, CA, United States of America

Sean Arin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Sean Arin: Pioneering Advances in Isotachophoresis

Introduction

Sean Arin is a notable inventor based in Oakland, CA. With three patents to his name, Arin has made significant contributions to the field of fluidic systems, particularly focused on the processing and extraction of nucleic acids. His work is instrumental in enhancing methodologies that are pivotal for various analytical applications across multiple scientific domains.

Latest Patents

Among Sean Arin's most recent innovations is a patent concerning "Systems, devices, and methods for isotachophoresis." This invention relates to fluidic systems and devices that enable the processing, extracting, or purifying of one or more analytes. These systems are specifically tailored to extract nucleic acids, including non-crosslinked nucleic acids, from samples like tissues or cells. Furthermore, these systems facilitate multiplex parallel sample processing, significantly improving the efficiency of analyses in laboratory settings.

Career Highlights

Currently, Sean Arin is associated with Purigen Biosystems, Inc., where he continues to innovate within the domain of biosystems. His commitment to advancing technology in sample processing is reflected in his patented work, helping to streamline complex biological assays.

Collaborations

Arin's accomplishments can also be attributed to his collaboration with talented colleagues such as Lewis A. Marshall and Amy L. Hiddessen. Their collective expertise contributes to Purigen Biosystems' mission of developing leading-edge solutions for bioanalytical applications.

Conclusion

In summary, Sean Arin stands out as an influential inventor dedicated to enhancing isotachophoresis techniques through his innovative patents. His continuous efforts at Purigen Biosystems, backed by collaborative partnerships, pave the way for advancements in nucleic acid extraction and sample processing methodologies, shaping the future of biosystems and analytical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…